| The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugs. | |
| | |
MedLine Citation:
|
PMID: 10918614 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This report examines the cytotoxicity of chemotherapeutic agents to primary bone marrow-derived IL-3-dependent cells. Such cells derived from p53-null mice were resistant to almost 100-fold higher concentrations of the inhibitors of deoxyribonucleotide synthesis FUdR, methotrexate and hydroxyurea than cells with wild-type p53. In contrast, the cytotoxicity of the DNA damaging agents X-irradiation, cisplatin or bleomycin was p53-independent. The topoisomerase II inhibitor etoposide induced p53-dependent death, which suggests that DNA damage may not be its primary mechanism of cytotoxicity in this cell type. An IL-3-dependent cell line which expresses wild-type p53 was used to demonstrate that the ability of cytotoxic drugs to increase p53 expression level does not control their ability to induce p53-dependent loss of clonigenicity. Finally, comparison with a p53-null IL-3-dependent cell line was used to show that absence of p53 delays the rate of entry into apoptosis following treatment with either DNA damaging agents or inhibitors of deoxyribonucleotide synthesis. This distinguishes short-term effects of p53 on rate of entry into apoptosis from its role in controlling ultimate cell survival. Oncogene (2000) 19, 3556 - 3559 |
| | |
Authors:
|
C Palacios; A Gutierrez del Arroyo; A Silva; M K Collins |
Related Documents
:
|
10622254 - P53 inhibition by the lana protein of kshv protects against cell death. 7885404 - The relative radiosensitivity of tk6 and wi-l2-ns lymphoblastoid cells derived from a c... 12539224 - Leptomycin b stabilizes and activates p53 in primary prostatic epithelial cells and ind... 19322654 - Nip1/duoxa1 expression in epithelial breast cancer cells: regulation of cell adhesion a... 10601604 - Enhancement of gene transfer efficiency into human cancer cells by modification of retr... 2226204 - The notch locus of drosophila is required in epidermal cells for epidermal development. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Oncogene Volume: 19 ISSN: 0950-9232 ISO Abbreviation: Oncogene Publication Date: 2000 Jul |
Date Detail:
|
Created Date: 2000-08-24 Completed Date: 2000-08-24 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8711562 Medline TA: Oncogene Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 3556-9 Citation Subset: IM |
Affiliation:
|
Department of Immunology, Windeyer Institute of Medical Science, 46 Cleveland Street, London W1P 6DB, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antineoplastic Agents / toxicity* Apoptosis / drug effects, genetics*, radiation effects Bleomycin / toxicity Bone Marrow Cells / drug effects, metabolism, radiation effects Cells, Cultured Cisplatin / toxicity Colony-Forming Units Assay DNA Damage DNA Replication / drug effects Drug Resistance, Neoplasm / genetics Enzyme Inhibitors / toxicity* Etoposide / toxicity Floxuridine / toxicity Genes, p53 Hematopoietic Stem Cells / drug effects*, metabolism, radiation effects Hydroxyurea / toxicity Interleukin-3 / pharmacology* Methotrexate / therapeutic use Mice Mice, Inbred C57BL Mice, Knockout Radiation Tolerance / genetics Tumor Suppressor Protein p53 / deficiency, physiology* |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 0/Enzyme Inhibitors; 0/Interleukin-3; 0/Tumor Suppressor Protein p53; 11056-06-7/Bleomycin; 127-07-1/Hydroxyurea; 15663-27-1/Cisplatin; 33419-42-0/Etoposide; 50-91-9/Floxuridine; 59-05-2/Methotrexate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta ...
Next Document: Evidence that Argos is an antagonistic ligand of the EGF receptor.